JINS HOLDINGS Inc. (JNDOF)
USD 22.75
(0.0%)
USD 22.75
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 51.41 Billion JPY | 5.33% |
| 2022 | 48.81 Billion JPY | 7.61% |
| 2021 | 45.36 Billion JPY | 10.42% |
| 2020 | 41.08 Billion JPY | 3.0% |
| 2019 | 39.88 Billion JPY | 12.72% |
| 2018 | 35.38 Billion JPY | 8.74% |
| 2017 | 32.54 Billion JPY | 5.5% |
| 2016 | 30.84 Billion JPY | 15.35% |
| 2015 | 26.73 Billion JPY | 15.15% |
| 2014 | 23.22 Billion JPY | 9.42% |
| 2013 | 21.22 Billion JPY | 47.57% |
| 2012 | 14.38 Billion JPY | 49.73% |
| 2011 | 9.6 Billion JPY | 42.39% |
| 2010 | 6.74 Billion JPY | 33.62% |
| 2009 | 5.04 Billion JPY | 25.17% |
| 2008 | 4.03 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 13.36 Billion JPY | 7.51% |
| 2024 Q1 | 13.25 Billion JPY | -0.21% |
| 2024 Q2 | 13.09 Billion JPY | -1.21% |
| 2023 Q3 | 12.68 Billion JPY | -0.37% |
| 2023 FY | 51.41 Billion JPY | 5.33% |
| 2023 Q4 | 13.28 Billion JPY | 4.75% |
| 2023 Q1 | 12.71 Billion JPY | 2.17% |
| 2023 Q2 | 12.73 Billion JPY | 0.09% |
| 2022 Q1 | 11.35 Billion JPY | -0.92% |
| 2022 FY | 48.81 Billion JPY | 7.61% |
| 2022 Q4 | 12.44 Billion JPY | -2.09% |
| 2022 Q3 | 12.71 Billion JPY | 3.39% |
| 2022 Q2 | 12.29 Billion JPY | 8.29% |
| 2021 Q3 | 11.5 Billion JPY | 0.85% |
| 2021 Q4 | 11.46 Billion JPY | -0.39% |
| 2021 Q1 | 10.98 Billion JPY | -1.98% |
| 2021 Q2 | 11.4 Billion JPY | 3.86% |
| 2021 FY | 45.36 Billion JPY | 10.42% |
| 2020 Q3 | 8.72 Billion JPY | -19.53% |
| 2020 Q1 | 10.3 Billion JPY | -2.89% |
| 2020 Q2 | 10.84 Billion JPY | 5.22% |
| 2020 Q4 | 11.2 Billion JPY | 28.45% |
| 2020 FY | 41.08 Billion JPY | 3.0% |
| 2019 FY | 39.88 Billion JPY | 12.72% |
| 2019 Q3 | 10.25 Billion JPY | 6.41% |
| 2019 Q1 | 9.37 Billion JPY | 1.26% |
| 2019 Q2 | 9.64 Billion JPY | 2.84% |
| 2019 Q4 | 10.61 Billion JPY | 3.45% |
| 2018 Q4 | 9.25 Billion JPY | 1.14% |
| 2018 Q1 | 8.36 Billion JPY | 0.71% |
| 2018 Q2 | 8.61 Billion JPY | 2.97% |
| 2018 Q3 | 9.15 Billion JPY | 6.29% |
| 2018 FY | 35.38 Billion JPY | 8.74% |
| 2017 FY | 32.54 Billion JPY | 5.5% |
| 2017 Q4 | 8.3 Billion JPY | 0.53% |
| 2017 Q3 | 8.26 Billion JPY | -0.27% |
| 2017 Q2 | 8.28 Billion JPY | 7.64% |
| 2017 Q1 | 7.69 Billion JPY | -1.85% |
| 2016 FY | 30.84 Billion JPY | 15.35% |
| 2016 Q4 | 7.83 Billion JPY | -3.96% |
| 2016 Q3 | 8.16 Billion JPY | 6.46% |
| 2016 Q2 | 7.66 Billion JPY | 6.84% |
| 2016 Q1 | 7.17 Billion JPY | -2.93% |
| 2015 Q1 | 5.95 Billion JPY | 6.46% |
| 2015 Q4 | 7.39 Billion JPY | 4.59% |
| 2015 Q3 | 7.06 Billion JPY | 11.81% |
| 2015 Q2 | 6.32 Billion JPY | 6.08% |
| 2015 FY | 26.73 Billion JPY | 15.15% |
| 2014 Q4 | 5.59 Billion JPY | -5.28% |
| 2014 FY | 23.22 Billion JPY | 9.42% |
| 2014 Q3 | 5.9 Billion JPY | -2.27% |
| 2014 Q2 | 6.04 Billion JPY | 6.67% |
| 2014 Q1 | 5.66 Billion JPY | -4.41% |
| 2013 Q4 | 5.93 Billion JPY | 1.07% |
| 2013 Q3 | 5.86 Billion JPY | 19.94% |
| 2013 FY | 21.22 Billion JPY | 47.57% |
| 2013 Q1 | 4.53 Billion JPY | 0.72% |
| 2013 Q2 | 4.89 Billion JPY | 7.95% |
| 2012 Q3 | 3.77 Billion JPY | 23.43% |
| 2012 Q4 | 4.49 Billion JPY | 19.06% |
| 2012 FY | 14.38 Billion JPY | 49.73% |
| 2012 Q1 | 3.04 Billion JPY | 18.33% |
| 2012 Q2 | 3.06 Billion JPY | 0.71% |
| 2011 Q4 | 2.56 Billion JPY | 2.26% |
| 2011 Q2 | 2.13 Billion JPY | -10.83% |
| 2011 Q3 | 2.51 Billion JPY | 17.85% |
| 2011 Q1 | 2.39 Billion JPY | 51.02% |
| 2011 FY | 9.6 Billion JPY | 42.39% |
| 2010 Q3 | 1.87 Billion JPY | 18.0% |
| 2010 FY | 6.74 Billion JPY | 33.62% |
| 2010 Q1 | 1.7 Billion JPY | 38.73% |
| 2010 Q4 | 1.58 Billion JPY | -15.38% |
| 2010 Q2 | 1.58 Billion JPY | -7.06% |
| 2009 Q3 | 1.3 Billion JPY | 3.8% |
| 2009 Q1 | 1.25 Billion JPY | 0.0% |
| 2009 Q4 | 1.22 Billion JPY | -5.85% |
| 2009 Q2 | 1.25 Billion JPY | 0.32% |
| 2009 FY | 5.04 Billion JPY | 25.17% |
| 2008 FY | 4.03 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | -1795573.355% |
| Ansell Limited | 495.5 Million USD | -10276.589% |
| Ansell Limited | 495.5 Million USD | -10276.589% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | -61993.78% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | -2970624.932% |
| Psykey, Inc. | 1.21 Million USD | -4236970.244% |
| ConvaTec Group Plc | 910.31 Million USD | -5548.15% |
| ConvaTec Group Plc | 872.5 Million USD | -5792.951% |
| Encision Inc. | 3.77 Million USD | -1361283.943% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -36256607.872% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -46771056.453% |
| Innovative MedTech Inc. | 6.09 Million USD | -842923.308% |
| LifePoint, Inc. | 7.42 Million USD | -692476.783% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | -809728.319% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | -6013467.251% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -7080686.742% |
| Reflect Scientific, Inc. | 1.06 Million USD | -4833598.255% |
| SmileDirectClub, Inc. | 517 Million USD | -9845.01% |
| Sector 10, Inc. | 39.84 Thousand USD | -129043168.748% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | -673.984% |
| SheerVision, Inc. | 2.33 Million USD | -2205047.89% |
| United Health Products, Inc. | 2.42 Million USD | -2118802.684% |
| Vasamed, Inc. | 4.67 Million USD | -1100198.443% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | -2006923.176% |
| Yubo International Biotech Limited | 1.25 Million USD | -4087428.57% |